onyx pharmaceuticals
Treatment shifts away from chemotherapy for multiple myeloma
December 10, 2014Research and Development, Sales and Marketing Kyprolis, carfilzomib, chemotherapy, myeloma, onyx pharmaceuticals
Results from a Phase III study of a new multiple myeloma offering have found promising results for a treatment that …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
